Targeting human γδ T cells as a potent and safe alternative to pan-T cells bispecific cell engagers

Author:

Boutin LolaORCID,Barjon Clément,Lafrance Laura,Senechal Eric,Bourges Dorothée,Vigne EmmanuelleORCID,Scotet EmmanuelORCID

Abstract

AbstractOver the past decade, an increasing number of immunotherapies aiming to improve the ability of the immune system to effectively eradicate tumor cells have been developed. Among them, targeting effector T cell subsets of the immune system with bispecific antibodies, called T Cell Engagers (TCEs), represents an attractive strategy. TCEs are designed to specifically direct cytotoxic T cells towards tumor cells, thereby inducing a strong activation leading to the lysis of tumor cells. New strategies for targeting specific T-cell subsets are currently being explored. In this study, we investigated the activity of different TCEs on both conventional alpha beta (αβ) T cells and unconventional gamma delta (γδ) T cells. We generated TCE molecules based on camelid single-domain antibodies (VHHs) that target the tumor-associated antigen CEACAM5 (CEA), together with particular T-cell receptor chains (TCRs) or a CD3 domain. Thein vitrobiological activity of the TCEs against the colon carcinoma cell line LS174T was measured using fresh and cultured human Vγ9Vδ2 and αβ T cells. We showed that Vγ9Vδ2 T cells display stronger antitumor activityin vitrothan αβ T cells when activated with a CD3xCEA TCE. Furthermore, restricting T cell activation to Vγ9Vδ2 T cells limits the production of pro-tumor factors and pro-inflammatory cytokines, which are often associated with toxicity in patients. Taken together, these results suggest that Vγ9Vδ2γδ T cell-specific TCEs may represent safe, novel, specific, and effective molecules for improving antitumor immunotherapies.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3